Massachusetts House Bill H4490

Massachusetts 2025-2026 Regular Session

• Introduced: 9/18/25
• Refer: 9/18/25

Caption

Prohibiting discrimination against 340b drug discount program participants

Impact

If passed, this legislation will make it illegal for insurance companies to apply different reimbursement rates or conditions for 340B-covered entities and contract pharmacies compared to non-340B entities. It establishes that any such discriminatory practices are unfair and will have implications for both the delivery of drug services and the financial operations of 340B entities. Specifically, it aims to protect patient choice by ensuring that patients are not steered away from 340B pharmacies in favor of others, affirming their rights to receive medications through entities designed to serve low-income individuals.

Summary

House Bill 4490 aims to prohibit discrimination against participants in the 340B drug discount program in Massachusetts. The bill seeks to amend various sections of the General Laws of Massachusetts pertaining to drug coverage to ensure that covered entities and their contract pharmacies receive equitable treatment compared to other pharmacies when it comes to reimbursement for 340B drugs. This initiative is focused on enhancing the accessibility and affordability of healthcare for underserved populations relying on these programs for their medications.

Contention

There may be contention surrounding the bill, particularly among healthcare stakeholders who might oppose the regulatory burden it imposes on insurers and pharmacies. Opposition may arise from concerns regarding how these changes might affect the broader healthcare system and the financial dynamics within drug pricing mechanisms. Proponents argue that ensuring equitable treatment within the healthcare system is critical for maintaining the integrity of the 340B program and enhancing access for vulnerable populations, while detractors may highlight potential market disruptions.